Koga et al., “Nuclear DNA Fragmentation and Expression of Bcl-2 in Primary Biiary Cirrhosis”, Hepatology, 25, pp. 1077-1084, 1997.* |
Adjei et al., “Cathepsin B Protease Activity But Not Interleukin 1 β-Converting Enzyme (ICE) Proteases Contributes to Camptothecin-Induced Apoptosis in a Human Hepatocellular Carcinoma Cell Line,” Abstract 481, Hepatology, 24(4 Part 2):247A (1996). |
Adjei et al., “Selective Induction of Apoptosis in Hep 3B Cells by Topoisomerase I Inhibitors: Evidence for a Protease-dependent Pathway That Does Not Activate Cysteine Protease P32,” J. Clin. Invest., 98(11):2588-2596 (1996). |
Adjei et al., “Selective Induction of Apoptosis In A Human Hepatocellular Carcinoma (HCC) Cell Line By The Topoisomerase I Inhibitor Camptothecin,” Abstract, Gastroenterology, 110(4 Suppl.):A483 (1996). |
Beaufay et al., “Analytical Study of Microsomes and Isolated Subcellular Membranes from Rat Liver I. Biochemical Methods,” J. Cell Biol., 61:188-200 (1974). |
Benedetti et al., “Subcellular changes and apoptosis induced by ethanol in rat liver,” J. Hepatology, 6(2):137-143 (1988). |
Bernardi, “Modulation of the Mitochondrial Cyclosporin A-sensitive Permeability Transition Pore by the Proton Electrochemical Gradient,” J. Biol. Chem., 267(13):8834-8839 (1992). |
Boise et al., “bcl-x, a bcl-2-Related Gene That Functions as a Dominant Regulator of Apoptotic Cell Death,” Cell, 74(4):597-608 (1993). |
Botla et al., “Ursodeoxycholate Inhibits the Mitochondrial Membrane Permeability Transition (MMPT) Induced by Glycochenodeoxycholate: A Mechanism for Ursodeoxycholate Cytoprotection?” Abstract 316, Hepatology, 20(4 Part 2):175A (1994). |
Botla et al., “Ursodeoxycholate (UDCA) Inhibits the Mitochondrial Membrane Permeability Transition Induced by Glycochenodeoxycholate: A Mechanism of UDCA Cytoprotection,” J. Pharmacol. Exp. Ther., 272(2):930-938 (1995). |
Bouscarel et al., “Alteration of cAMP-mediated hormonal responsiveness by bile acids in cells of nonhepatic origin,” Am. J. Physiol., 268(6):G908-G916 (1995). |
Bouscarel et al., “Ursodeoxycholic acid inhibits glucagon-induced cAMP formation in hamster hepatocytes: a role for PKC,” Am. J. Physiol., 268(2):G300-G310 (1995). |
Calmus et al., “Differential Effects of Chenodeoxycholic and Ursodeoxycholic Acids on Interleukin 1, Interleukin 6 and Tumor Necrosis Factor-α Production by Monocytes,” Hepatology, 16(3):719-723 (1992). |
Carter et al., “Intracellular hydrogen peroxide and superoxide anion detection in endothelial cells,” J. Leukocyte Biol., 55(2):253-258 (1994). |
Cathcart et al., “Detection of Picomole Levels of Hydroperoxides Using a Fluorescent Dichlorofluorescein Assay,” Anal. Biochem., 134:111-116 (1983). |
Chazouillères et al., “Ursodeoxycholic acid for primary sclerosing cholangitis,” J. Hepatology, 11(1):120-123 (1990). |
Columbano, “Cell Death: Current Difficulties in Discriminating Apoptosis from Necrosis in the Context of Pathological Processes in Vivo,” J. Cell. Biochem., 58:181-190 (1995). |
Committee on Care and Use of Laboratory Animals of the Institute of Laboratory Animal Resources Commission on Life Sciences, “NIH Publication No. 85-23: Guide for the Care and Use of Laboratory Animals,” US Dept. of Health and Human Services, National Institute of Health, Bethesda, MD, 47 pages (1985). |
Dupourque et al., “[20] Cytoplasmic and Mitochondrial Malate Dehydrogenases from Beef Kidney,” Methods Enzymol. 13:116-122 (1969). |
Earnest et al., “Chemoprevention of Azoxymethane-induced Colonic Carcinogenesis by Supplemental Dietary Ursodeoxycholic Acid,” Cancer Res., 54(19):5071-5074 (1994). |
Fan et al., “The retinoblastoma gene product inhibits TGF-β1 induced apoptosis in primary rat hepatocytes and human HuH-7 hepatoma cells,” Oncogene, 12(9):1909-1919 (1996). |
Fan et al., “Regulation of Apoptosis-Associated Genes in the Regenerating Liver,” Semin. Liver Dis., 18(2):123-140 (May 1998). |
Goldin et al., “Apoptotic bodies in a murine model of alcoholic liver disease: reversibility of ethanol-induced changes,” J. Pathol., 171:73-76 (1993). |
Haas-Kogan et al., “Inhibition of apoptosis by the retinoblastoma gene product,” EMBO J., 14(3):461-472 (1995). |
Hanif et al., “Bile acids induce apoptosis in the colon of mice in vivo,” Abstract A526, Gastroenterology, 110(4):156 (1996). |
Harnois et al., “BCL-2 is Overexpressed and Alters the Threshold for Apoptosis in a Cholangiocarcinoma Cell Line,” Abstract, Gastroenterology, 110(4):A1205 (1996). |
Herrera et al., “TGF β-induced Growth Inhibition in Primary Fibroblasts Requires the Retinoblastoma Protein,” Mol. Biol. Cell. 7(9):1335-1342 (1996). |
Heuman et al., “Conjugates of Ursodeoxycholate Protect Against Cholestasis and Hepatocellular Necrosis Caused by More Hydrophobic Bile Salts,” Gastroenterology, 100(1):203-211 (1991). |
Heuman et al., “Conjugates of Ursodeoxycholate Protect Against Cytotoxicity of More Hydrophobic Bile Salts: In Vitro Studies in Rat Hepatocytes and Human Erythrocytes,” Hepatology, 14(5):920-926 (1991). |
Heuman et al., “Ursodeoxycholate Conjugates Protect Against Disruption of Cholesterol-Rich Membranes by Bile Salts,” Gastroenterology, 106(5):1333-1341 (1994). |
Hirano et al., “Induction of the transcription factor AP-1 in cultured human colon adenocarcinoma cells following exposure to bile acids,” Carcinogenesis, 17(3):427-433 (1996). |
Jacobson et al., “Programmed cell death and Bcl-2 protection in the absence of a nucleus,” EMBO J., 13(8):1899-1910 (1994). |
Jänicke et al., “Specific cleavage of the retinoblastoma protein by an ICE-like protease in apoptosis,” EMBO J., 15(24):6969-6978 (1996). |
Jones et al., “Bile Salt-Induced Hepatocyte Apoptosis Involves Activation of Protein Kinase C,” Abstract, Gastroenterology, 110(4 Suppl.):A1224 (1996). |
Jones et al., “PKC Contributes to Bile Salt-Induced Apoptosis of Hepatocytes,” Abstract 2946, FASEB Journal, 11(3):A509 (1997). |
Jones et al., “Bile salt-induced apoptosis of hepatocytes involves activation of protein kinase C,” Am. J. Physiol., 272(5):G1109-G1115 (May, 1997). |
Kandell et al., “Bile Salt/Acid Induction of DNA Damage in Bacterial and Mammalian Cells: Implications for Colon Cancer,” Nutr. Cancer, 16(3&4):227-238 (1991). |
Koga et al., “Nuclear DNA Fragmentation and Expression of Bcl-2 in Primary Biliary Cirrhosis,” Hepatology, 25(5):1077-1084 (May 1997). |
Kren et al., “Differential Regulation of Multiple Gap Junction Transcripts and Proteins during Rat Liver Regeneration,” J. Cell Biol., 123(1):707-718 (1993). |
Kren et al., “Posttranscriptional regulation of mRNA levels in rat liver associated with deoxycholic acid feeding,” Am. J. Physiol., 269(6):G961-G973 (1995). |
Kroemer et al., “The biochemistry of programmed cell death,” FASEB J., 9:1277-1287 (1995). |
Kurosawa et al., “Hepatocytes in the bile duct-ligated rat express Bcl-2,” Am. J.Physiol., 272(6):G1587-G1593 (Jun. 1997). |
Kwo et al., “Ursodeoxycholate and its Conjugates Protect Against Glycodeoxycholate-Induced Apoptosis,” Abstract 640, Hepatology, 20(4 Part 2):256A (1994). |
Kwo et al., “Nuclear serine protease activity contributes to bile acid-induced apoptosis in hepatocytes,” Am. J. Physiol., 268(4):G613-G621 (1995). |
LaRusso et al., “Coordinate Secretion of Acid Hydrolases in Rat Bile; Hepatocyte Exocytosis of Lysosomal Protein?” J. Clin. Invest., 64:948-954 (1979). |
Lawson et al., “Chapter 5: Mass Spectrometry of Bile Acids,” The Bile Acids, Chemistry, Physiology, and Metabolism, vol. 4: Methods and Applications, Setchell et al., eds., Plenum Press, New York, Title page, publication page, table of contents, and pp. 167-267 (1988). |
Lindor et al., “The Combination of Ursodeoxycholic Acid (UDCA) and Methotrexate (MTX) for Patients with Primary Biliary Cirrhosis (PBC): The Results of a Pilot Study,” Abstract 421, Hepatology, 20(1 Part 2):202A (1994). |
Mariash et al., “Rapid Synergistic Interaction between Thyroid Hormone and Carbohydrate on mRNAS14 Induction,” J. Biol. Chem., 261(12):9583-9586 (1986). |
Nagata et al., “The Fas Death Factor,” Science, 267(5203):1449-1456 (1995). |
Nishigaki et al., “Ursodeoxycholic Acid Corrects Defective Natural Killer Activity by Inhibiting Prostaglandin E2 Production in Primary Biliary Cirrhosis,” Dig. Dis. Sciences, 41(7):1487-1493 (1996). |
Oberhammer et al., “Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor β1,” Proc. Natl. Acad. Sci. USA, 89(9):5408-5412 (1992). |
Ogasawara et al., “Lethal effect of the anti-Fas antibody in mice,” Nature, 364(6440):806-809 (1993). |
Pastorino et al., “Cyclosporin and Carnitine Prevent the Anoxic Death of Cultured Hepatocytes by Inhibiting the Mitochondrial Permeability Transition,” J. Biol. Chem., 268(19):13791-13798 (1993). |
Patel et al., “Increases of Intracellular Magnesium Promote Glycodeoxycholate-induced Apoptosis in Rat Hepatocytes,” J. Clin. Invest., 94(6):2183-2192 (1994). |
Patel et al., “Hepatocyte Apoptosis Induced by Glycodeoxycholate is Mediated By a Rise in Cytosolic Free Magnesium,” Abstract, Gastroenterology, 106(4 Suppl.):A958 (1994). |
Patel et al., “Inhibition of Bile Salt Induced Hepatocyte Apoptosis by the Novel Antioxidant Lazaroid U83836E,” Abstract 2422, FASEB J., 9(3):A418 (1995). |
Patel et al., “Apoptosis and Hepatobiliary Disease,” Hepatology, 21(5):1725-1741 (1995). |
Patel et al., “The role of proteases during apoptosis,” FASEB J., 10(5):587-597 (1996). |
Patel et al., “Inhibition of Bile-Salt-Induced Hepatocyte Apoptosis by the Antioxidant Lazaroid U83836E,” Toxicol. Appl. Pharmacol., 142(1):116-122 (Jan. 1997). |
Podda et al., “Effects of Ursodeoxycholic Acid and Taurine on Serum Liver Enzymes and Bile Acids in Chronic Hepatitis,” Gastroenterology, 98(4):1044-1050 (1990). |
Poupon et al., “Ursodiol for the Long-term Treatment of Primary Biliary Cirrhosis,” N. Engl. J. Med., 330(19):1342-1347 (1994). |
Promega, “Apoptosis Detection Systems from Promega,” Bench Press, Promega Newsletter, Issue 4, 1 page (Oct. 1998). |
Quist et al., “Activation of Mast Cells by Bile Acids,” Gastroenterology, 101(2):446-456 (1991). |
Reed, “Double identity for proteins of the Bcl-2 family,” Nature, 387(6635):773-776 (Jun. 1997). |
Roberts et al., “Purification and Characterization of the Novel Nuclear Serine Protease Mediating Bile Salt-Induced Apoptosis of Hepatocytes,” Abstract, Gastroenterology, 110(4 Suppl.):A1305 (1996). |
Roberts et al., “Translocation of cathepsin B from the cytoplasm to the nucleus contributes to bile salt-induced hepatocyte apoptosis,” Abstract 508, 47th Ann. Meeting, Am. Assoc. for the Study of Liver Diseases, Nov. 8-12, Hepatology, 24(4 Part 2):253A (1996). |
Rodrigues et al., “A Novel Role for Ursodeoxycholic Acid in Modulating Apoptosis in Rat Liver, Isolated Rat Hepatocytes, and Human Hepatoma Cells,” Nov. 7-11, 17 pages (Nov. 1997). |
Rodrigues et al., “Ursodeoxycholic Acid May Inhibit Deoxycholic Acid-Induced Apoptosis by Modulating Mitochondrial Transmembrane Potential and Reactive Oxygen Species Production,” Mol. Med., 4(3):165-178 (Mar. 1998). |
Rodrigues et al., “A Novel Role for Ursodeoxycholic Acid in Inhibiting Apoptosis by Modulating Mitochondrial Membrane Perturbation,” J. Clin. Invest., 101(12):2790-2799 (Jun. 15, 1998). |
Rodrigues et al., “Ursodeoxycholic acid prevents cytochrome c release in apoptosis by inhibiting mitochondrial membrane depolarization and channel formation,” Cell Death Differ., 6(9):842-854 (Sep. 1999). |
Schulze-Osthoff et al., “Cell Nucleus and DNA Fragmentation Are Not Required for Apoptosis,” J. Cell Biol., 127(1):15-20 (1994). |
Schmucker et al., “Hepatic Injury Induced by Bile Salts: Correlation Between Biochemical and Morphological Events,” Hepatology, 12(5):1216-1221 (1990). |
Setchell et al., “Metabolism of orally administered tauroursodeoxycholic acid in patients with primary biliary cirrhosis,” Gut, 38(3):439-446 (1996). |
Setchell et al., “Bile Acid Concentrations in Human and Rat Liver Tissue and in Hepatocyte Nuclei,” Gasroenterology, 112(1):226-235 (Jan. 1997). |
Silva et al., “Bilrubin-Induced Apoptosis in Asrocytes is Prevented By Ursodeoxycholic Acid,” Abstract, American Assn. for the Study of Liver Diseases, Nov. 4-10, Chicago (Nov. 1998). |
Sokol et al., “Oxidant Injury to Hepatic Mitochondrial Lipids in Rats With Dietary Copper Overload,” Gastroenterology, 99(4):1061-1071 (1990). |
Sokol et al., “Evidence for Involvement of Oxygen Free Radicals in Bile Acid Toxicity to Isolate Rat Hepatocytes,” Hepatology, 17(5):869-881 (1993). |
Spivey et al., “Tauroursodeoxycholate Prevents Glycochenodeoxycholate Induced Nonlysosomal Proteolysis and Cytotoxicity in Isolated Rat Hepatocytes,” Abstract 445, Hepatology, 16(4 Part 2):156A (1992). |
Spivey et al., “Glycochenodeoxycholate-induced Lethal Hepatocellular Injury in Rat Hepatocytes,” J. Clin. Invest. 92(1):17-24 (1993). |
Stefaniwsky et al., “Ursodeoxycholic Acid Treatment of Bile Reflux Gastritis,” Gastroenterology, 89(5):1000-1004 (1985). |
Suchy, “Hepatocellular Transport of Bile Acids,” Sem. Liver Dis., 13(3):235-247 (1993). |
Thompson, “Apoptosis in the Pathogenesis and Treatment of Disease,” Science, 267(5203):1456-1462 (1995). |
Trembley et al., “Differential Regulation of Cyclin B1 RNA and Protein Expression during Hepatocyte Growth in Vivo,” Cell Growth Differ., 7(7):903-916 (1996). |
Walajtys-Rhode et al., “The Role of the Matrix Calcium Level in the Enhancement of Mitochondrial Pyruvate Carboxylation by Glucagon Pretreatment,” J. Biol. Chem., 267(1):370-379 (1992). |
Walker et al., “Detection of the Initial Stages of DNA Fragmentation in Apoptosis,” Bio Techniques, 15(6):1032-1040 (1993). |
Wyllie et al., “Cell Death: The Significance of Apoptosis,” Int. Rev. Cytol., 68:251-306 (1980). |
Yang et al., “Bad, a Heterodimeric Partner for Bcl-xL, and Bcl-2, Displaces Bax and Promotes Cell Death,” Cell, 80(2):285-291 (1995). |
Yoshikawa et al., “Immunomodulatory Effects of Urosodeoxycholic Acid on Immune Responses,” Hepatology, 16(2):358-364 (1992). |
Zamzami et al., “Reduction in Mitochondrial Potential Constitutes an Early Irreversible Step of Programmed Lymphocyte Death in Vivo,” J. Exp. Med., 181(5):1661-1672 (1995). |